lenacapavir yeztugo - Search News

News

HIV prevention drug lenacapavir approved by FDA

CBS News on MSN · 2d

HIV prevention drug lenacapavir approved by FDA as twice-yearly injection

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo from company Gilead Sciences, remained HIV negative.

Public Broadcasting Service (PBS) · 10h

6 things to know about lenacapavir, what experts call a ‘wonder drug’ for preventing HIV

The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts say lenacapavir is easier to administer, and each dose lasts longer compared to other medications.

The FDA Just Approved a Long-Lasting Injection to Prevent HIV

Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming infected with HIV. But big questions remain over the drug’s affordability.

1h

USFDA Okays Lenacapavir: Affordable, Generic India-Made Drug Key To Boost Global HIV Prevention

While Gilead Sciences' HIV prevention drug lenacapavir got approved by the US Food and Drug Administration (FDA), its made- ...

Audacy on MSN9h

There's a new, highly effective HIV drug on the market

A revolutionary new preventative medicine that protects against the HIV virus has just been approved by the U.S. Food and ...

20h

FDA Approves Gilead's 'Game Changing' Twice-Yearly Shot To Prevent HIV Transmission, Critics Slam $28K Price Tag

Gilead's FDA-approved Yeztugo, a twice-yearly injectable HIV PrEP, showed near-perfect trial efficacy but faces backlash over ...

Managed Healthcare Executive1d

With Lenacapavir 'You've Basically Got a Vaccine.' But Reaching the People Who Would Benefit Is Difficult, Says Gates Foundation Expert

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results